Uncategorized
2021 Report on Ocular Pain Drugs in Development – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Ocular Pain (Eye Pain) (Central Nervous System) - Drugs in Development, 2021" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of the Ocular Pain (Eye Pain) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ocular Pain (Eye Pain), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type.